The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple Sclerosis

Cladribine Tablets (MAVENCLAD(®)) are used to treat relapsing multiple sclerosis (MS). The recommended dose is 3.5 mg/kg, consisting of 2 annual courses, each comprising 2 treatment weeks 1 month apart. We reviewed the clinical pharmacology of Cladribine Tablets in patients with MS, including pharma...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Clin Pharmacokinet
Main Authors: Hermann, Robert, Karlsson, Mats O., Novakovic, Ana M., Terranova, Nadia, Fluck, Markus, Munafo, Alain
Format: Artigo
Sprog:Inglês
Udgivet: Springer International Publishing 2018
Fag:
Review Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6373393/
https://ncbi.nlm.nih.gov/pubmed/29987837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40262-018-0695-9
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker